Kala Pharmaceuticals, Inc. Made Big Gain
Thu, Jun 27, 2024 at 07:29 PM
Kala Pharmaceuticals, Inc. (KALA:NASDAQ) jumped higher at $6.45, a gain of 42.7%. On Thu, Jun 27, 2024, KALA:NASDAQ touched a New 2-Week High of $6.45. The stock appeared on our News Catalysts scanner on Thu, Jun 27, 2024 at 09:07 AM in the 'PRIVATE PLACEMENT' category. From Thu, Jun 13, 2024, the stock recorded 22.22% Up Days and 30.00% Green Days
About Kala Pharmaceuticals, Inc. (KALA:NASDAQ)
Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.
Top 10 Gainers:
- Vinco Ventures Inc. (BBIG:NASDAQ), 100%
- Assure Holdings Corp. (IONM:NASDAQ), 82.76%
- Inspire Veterinary Partners Inc. (IVP:NASDAQ), 64.44%
- XBP Europe Holdings Inc. (XBP:NASDAQ), 58.2%
- Denali Capital Acquisition Corp. (DECA:NASDAQ), 46.59%
- Kala Pharmaceuticals, Inc. (KALA:NASDAQ), 42.7%
- Alset EHome International Inc. (AEI:NASDAQ), 37.76%
- CASI Pharmaceuticals, Inc. (CASI:NASDAQ), 37.25%
- Destiny Tech100 Inc. (DXYZ:NYSE), 33.7%
- Onconetix Inc Com (ONCO:NASDAQ), 32.19%